Neurology® Podcast
Dr. Nadia Khalil talks with Dr. Jean Bouchart about the diagnostic approach to intracerebral hemorrhage, the causes of cerebral small vessel disease, and the interpretation of biomolecular tests. Read the related article in . Disclosures can be found at .
info_outlineNeurology® Podcast
The June 2025 replay features four previously released stroke episodes. It begins with Dr. Cheryl Bushnell discussing the 2024 primary stroke prevention guidelines, followed by an interview with Dr. Phillip Ferdinand on the connection between smoking and young cryptogenic stroke. Next, Dr. Aaron Shoskes addresses the vascular risk burden in young adults with stroke. The replay concludes with Dr. Seemant Chaturvedi's overview from the International Stroke Conference. Podcast links: Article links: Disclosures can be found at .
info_outlineNeurology® Podcast
Dr. Justin Abbatemarco talks with Drs. Sumanth Reddy and Jeffrey Gelfand about the complexities of small vessel predominant primary CNS vasculitis, clinical features, and the impact of early intensive immunosuppressive therapy on remission. Read the related article in . Disclosures can be found at .
info_outlineNeurology® Podcast
Dr. Greg Cooper talks with Dr. David A. Wolk about limbic predominant age-related TDP-43 encephalopathy (LATE) discussing its clinical features, diagnostic criteria, and the importance of recognizing this condition in the context of Alzheimer disease. Read the related . Disclosures can be found at Neurology.org.
info_outlineNeurology® Podcast
Dr. Stacey Clardy talks with Dr. Elia Sechi about the importance of understanding lab test results, the performance characteristics of assays, and the real-world implications of false positives in myasthenia gravis testing. Read the related article in . Disclosures can be found at .
info_outlineNeurology® Podcast
Dr. Roy E. Strowd talks with Dr. Susannah Cornes about a teaching incentive initiative designed to support and reward faculty in academic neurology. Read the related article in . Disclosures can be found at .
info_outlineNeurology® Podcast
Dr. Jeff Ratliff talks with Dr. Per Borghammer about the classification of Lewy body disease into brain-first and body-first subtypes, with a focus on the newly identified parasympathetic and sympathetic subtypes within the body-first category. Read the related article in . Disclosures can be found at .
info_outlineNeurology® Podcast
Dr. Stacey Clardy talks with Dr. Janis Miyasaki about her journey into neurology, the integration of palliative care into neurologic practice, and the critical importance of patient-centered care. Read more about the . Disclosures can be found at .
info_outlineNeurology® Podcast
Dr. Jessica Ailani talks with Dr. Kathleen Digre about the evolution of spontaneous intracranial hypotension (SIH) diagnosis and treatment over the past decade. Disclosures can be found at .
info_outlineNeurology® Podcast
Dr. Dan Ackerman talks with Dr. Trey Bateman about the significance of blood-based biomarkers in Alzheimer disease. to get access to the recordings and the ability to claim CME through March 1, 2026. Disclosures can be found at .
info_outlineThe May 2025 recall features four previously posted episodes on myasthenia gravis. The first episode has Dr. Fredrik Piehl discussing rituximab for new-onset generalized MG. In the second episode, Dr. Vera Bril explores the potential use of immunoglobulin as a corticosteroid-sparing agent in MG patients. The third episode features Dr. Ali A. Habib discussing trends in hospital admissions and in-hospital mortality for adult MG patients. The series concludes with Dr. Jennifer Morganroth addressing the increase in thymectomy procedures post-MGTX trial, disparities in access to these surgeries among different demographic groups, and the rise of minimally invasive surgical techniques.
Podcast links:
Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis
Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis
Hospitalizations and Mortality from MG Hospitalizations and Mortality From Myasthenia Gravis
Trends and Disparities in the Utilization of Thymectomy for MG in the US
Article links:
Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis
Hospitalizations and Mortality From Myasthenia Gravis
Trends and Disparities in the Utilization of Thymectomy for Myasthenia Gravis in the United States
Disclosures can be found at Neurology.org.